Yantai, China | Datwyler

Yantai Xinhui Packing Co., Ltd.

No. 1 Fuquan Road
Fushan District
Yantai City, Shandong Province
China

xinhuipackage.com

sales@ytxinhui.com
T +86 535 6433010

Press release

Datwyler expands into China with acquisition of Yantai Xinhui Packing (#)Anchor

03. March 2022

The Switzerland-based maker of system-critical pharmaceutical packaging and medical device components will bring its 100-year history of manufacturing excellence to its eighth plant worldwide to meet the demands of the evolving Chinese healthcare market.

Datwyler has completed its acquisition of Chinese Yantai Xinhui Packing, representing the first foothold in the largest emerging pharmaceutical market for its Healthcare business. Located in Shandong, Xinhui manufactures elastomer components, such as isoprene rubber discs, which complement Datwyler’s current portfolio of pharmaceutical packaging and medical solutions. This addition will help Datwyler—headquartered in Altdorf, Switzerland—strengthen local production, innovation, and customer support for drug manufacturers in China.

Datwyler will bring its technological expertise,100 years of global industry experience, its quality-first manufacturing philosophy, and its financial power to invest in the expansion of the already modernized production capacity. These factors will help position Datwyler as the market leader for innovation and quality control. Datwyler’s Healthcare Solutions business manufactures high-quality, system-critical elastomer components, including NeoFlex™ plungers for syringe applications and OmniFlex stoppers™ as well as other sealing solutions for vials and cartridges. Datwyler will later announce which best-in-class products from its current portfolio will be manufactured at the Xinhui facility for the Chinese market.

China’s growing middle class and expectations for 10 percent annual growth YOY in applicable healthcare markets make the country a strategically important addition to our global network. We are proud to welcome Xinhui’s 170 employees into our family. Together, Datwyler and Xinhui can create an optimal platform for local production and marketing of a wide and competitive product range.
Dirk Borghs
COO Healthcare Solutions

Xinhui’s recently refurbished plant will operate at Datwyler’s Advanced production level, representing a proven and reliable facility for manufacturing components that meet the highest regulatory expectations and cater to small molecule drugs which require extraordinary quality and production flexibility. The current plant generates annual revenue of $16 million. However, production capacity could stand to double with activation of spare capacity within the plant’s current footprint.

For nearly 20 years, Xinhui has manufactured high-quality elastomer components for critical healthcare applications. Datwyler’s shared commitment to quality, sophisticated manufacturing principles, and a collaborative environment made the company an ideal fit for our dedicated workforce to continue to serve China’s demanding healthcare market.
Liu Xinsheng, Chairman of Yantai Xinhui Packing

With the acquisition, Datwyler now boasts a truly global production footprint with eight healthcare production facilities across China, India, Italy, Germany, Belgium, and the USA to support more than $450 million USD in sales in over 100 countries.

The Chinese version of the press release
is available for download.